Comparable Efficacy and Safety Among Patients with and Without Aura: Orally Inhaled Dihydroergotamine (MAP0004) for the Acute Treatment of Migraine

Winner P.; Holdbrook F.; Davar G.

首页> 外文期刊>Headache >Comparable Efficacy and Safety Among Patients with and Without Aura: Orally Inhaled Dihydroergotamine (MAP0004) for the Acute Treatment of Migraine

【24h】

Comparable Efficacy and Safety Among Patients with and Without Aura: Orally Inhaled Dihydroergotamine (MAP0004) for the Acute Treatment of Migraine

机译：有或没有先兆的患者之间的可比疗效和安全性：口服吸入二氢麦角胺（MAP0004）用于急性偏头痛的治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Headache》 |2014年第s1期|共2页
作者
Winner P.; Holdbrook F.; Davar G.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类诊断学;
关键词

相似文献

外文文献
中文文献
专利

1. Comparable Efficacy and Safety Among Patients with and Without Aura: Orally Inhaled Dihydroergotamine (MAP0004) for the Acute Treatment of Migraine [J] . Winner P., Holdbrook F., Davar G. Headache . 2014,第S1期

机译：有或没有先兆的患者之间的可比疗效和安全性：口服吸入二氢麦角胺（MAP0004）用于急性偏头痛的治疗
2. MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: Efficacy of early and late treatments [J] . TepperS.J., KoriS.H., GoadsbyP.J., Mayo Clinic Proceedings . 2011,第10期

机译：MAP0004，口服吸入二氢麦角胺用于偏头痛的急性治疗：早期和晚期治疗的功效
3. Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia [J] . TepperS.J., KoriS.H., BorlandS.W., Headache . 2012,第1期

机译：MAP0004口服吸入性DHE在治疗有或无痛觉异常的偏头痛中的功效和安全性
4. SAFETY AND USABILITY FACTORS IN DEVELOPMENT OF A NOVEL, AUTOMATED TREATMENT DEVICE FOR ACUTE MIGRAINE [C] . David M. George, Guido Pagnacco, Kevin E. Willey, Annual rocky mountain bioengineering symposium;International ISA biomedical sciences instrumentation symposium . 2017

机译：开发新型自动治疗急性偏头痛的安全性和可用性因素
5. Neuropsychological functioning of migraine patients with- and without aura, and cerebral hemisphere laterality. [D] . Milovan, Denise L. 2006

机译：偏头痛患者有或没有先兆以及脑半球偏侧的神经心理功能。
6. MAP0004 Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine: Efficacy of Early and Late Treatments [O] . Stewart J. Tepper, Shashidhar H. Kori, Peter J. Goadsby, 2011

机译：MAP0004口服吸入的二氢麦角胺用于偏头痛的急性治疗：早期和晚期治疗的功效
7. MAP0004, Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine:Efficacy of Early and Late Treatments (vol 86, pg 948, 2011) [O] . Tepper, Stewart J., Kori, Shashidhar H., Goadsby, Peter J., 2011

机译：MAP0004，口服吸入二氢麦角胺用于偏头痛的急性治疗：早期和晚期治疗的功效（第86卷，第948页，2011年）

Comparable Efficacy and Safety Among Patients with and Without Aura: Orally Inhaled Dihydroergotamine (MAP0004) for the Acute Treatment of Migraine

著录项

相似文献

相关主题

期刊订阅